January 19, 2023
Via: Contract PharmaSun Pharmaceutical Industries and Concert Pharmaceuticals, Inc. entered a definitive agreement under which Sun Pharma will acquire Concert through an upfront payment of $576 million. Concert stockholders will also receive up to an additional $3.50 per share of common stock […]
February 27, 2024
March 8, 2024
February 29, 2024